Kang Chunmiao, Sun Pengfeng, Yang Runqin, Zhang Changming, Ning Wenfeng, Liu Hongsheng
Department of Ultrasound, Shaanxi Provincial People's Hospital, Xi'an, China.
Department of Radiology, Xi'an Central Hospital Affiliated to Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Front Oncol. 2023 Mar 24;13:1094768. doi: 10.3389/fonc.2023.1094768. eCollection 2023.
This study aimed to develop a radiomics nomogram to predict pathological response (PR) after induction chemotherapy (IC) and overall survival (OS) in patients with advanced laryngeal cancer (LC).
This retrospective study included patients with LC (n = 114) who had undergone contrast computerized tomography (CT); patients were randomly assigned to training (n = 81) and validation cohorts (n = 33). Potential radiomics scores were calculated to establish a model for predicting the PR status using least absolute shrinkage and selection operator (LASSO) regression. Multivariable logistic regression analyses were performed to select significant variables for predicting PR status. Kaplan-Meier analysis was performed to assess the risk stratification ability of PR and radiomics score (rad-score) for predicting OS. A prognostic nomogram was developed by integrating radiomics features and clinicopathological characteristics using multivariate Cox regression. All LC patients were stratified as low- and high-risk by the median CT radiomic score, C-index, calibration curve. Additionally, decision curve analysis (DCA) of the nomogram was performed to test model performance and clinical usefulness.
Overall, PR rates were 45.6% (37/81) and 39.3% (13/33) in the training and validation cohorts, respectively. Eight features were optimally selected to build a rad-score model, which was significantly associated with PR and OS. The median OS in the PR group was significantly shorter than that in the non-PR group in both cohorts. Multivariate Cox analysis revealed that volume [hazard ratio, (HR) = 1.43], N stage (HR = 1.46), and rad-score (HR = 2.65) were independent risk factors associated with OS. The above four variables were applied to develop a nomogram for predicting OS, and the DCAs indicated that the predictive performance of the nomogram was better than that of the clinical model.
For patients with advanced LC, CT radiomics score was an independent biomarker for estimating PR after IC. Moreover, the nomogram that incorporated radiomics features and clinicopathological factors performed better for individualized OS estimation.
本研究旨在开发一种放射组学列线图,以预测晚期喉癌(LC)患者诱导化疗(IC)后的病理反应(PR)和总生存期(OS)。
本回顾性研究纳入了114例接受增强计算机断层扫描(CT)的LC患者;患者被随机分配到训练队列(n = 81)和验证队列(n = 33)。计算潜在的放射组学评分,使用最小绝对收缩和选择算子(LASSO)回归建立预测PR状态的模型。进行多变量逻辑回归分析以选择预测PR状态的显著变量。进行Kaplan-Meier分析以评估PR和放射组学评分(rad-score)预测OS的风险分层能力。通过使用多变量Cox回归整合放射组学特征和临床病理特征来开发预后列线图。所有LC患者根据CT放射组学评分中位数、C指数、校准曲线分为低风险和高风险。此外,对列线图进行决策曲线分析(DCA)以测试模型性能和临床实用性。
总体而言,训练队列和验证队列中的PR率分别为45.6%(37/81)和39.3%(13/33)。最佳选择了八个特征来构建rad-score模型,该模型与PR和OS显著相关。两个队列中PR组的中位OS均显著短于非PR组。多变量Cox分析显示,体积[风险比,(HR)= 1.43]、N分期(HR = 1.46)和rad-score(HR = 2.65)是与OS相关的独立危险因素。应用上述四个变量开发了预测OS的列线图,DCA表明列线图的预测性能优于临床模型。
对于晚期LC患者,CT放射组学评分是估计IC后PR的独立生物标志物。此外,结合放射组学特征和临床病理因素的列线图在个体化OS估计方面表现更好。